Palisade Bio PALI
NASDAQ PALI
$1.40 -0.03 (-2.10%)
At close: Oct 21, 2026 · 4:00 PM EDT

Palisade Bio (PALI) Long-Term Debt Issuances (2013 - 2014)

Updated

Palisade Bio (PALI) recorded Long-Term Debt Issuances of $450,000 in FY2020, up 8.6% from $414,320 in FY2019.

Analysis

Palisade Bio (PALI) Long-Term Debt Issuances (2013 - 2014) Analysis & Trends

Starting with FY2013, Palisade Bio's Long-Term Debt Issuances history includes 7 years.

  • Annual Long-Term Debt Issuances has increased for four straight years, with a four-year compound annual growth rate of 9.5% (FY2016 to FY2020).
  • The FY2020 figure is the highest annual Long-Term Debt Issuances since FY2014.
  • Per Business Quant data, PALI's Long-Term Debt Issuances was $414,320 in FY2019 (+18.5%), $349,578 in FY2018 (+0.8%), $346,863 in FY2017 (+10.6%) and $313,483 in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Palisade Bio 294.88 Mn -101.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 4.21 Mn
Mar 31, 2013 7.55 Mn
API Access

Palisade Bio Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=PALI&period=max&api_key=YOUR_API_KEY